Annabi
case precedent
Mentioned in 4 documents. Roles: case precedent, Precedent-setting case or individual influencing the outcome, relevant case law precedent, relevant to a prior case or decision that controls the outcome here
Annabi is mentioned in documents or reporting related to the Epstein case. Being mentioned does not imply any wrongdoing, criminal conduct, or inappropriate behavior.
At a Glance
Click values for sourcesSources
5 sources for document mentions
Directory of Private Cannabis Companies Featured in House Oversight Report
2025-11-11
“The passage lists several private cannabis producers and their products without mentioning any high‑”
Cannabis Industry Company Listings in 2017 Investment Report
2025-11-11
“The passage lists several small cannabis businesses and a research firm with no mention of high‑prof”
Cannabis Investment Report – Comparison of U.S. Stock Market Listing Requirements (Dec 2017)
2025-11-11
“The passage only provides generic data on listing standards for Nasdaq, NYSE, and OTC markets. It co”
Canadian Public Cannabis Companies Market Overview (Nov 2017)
2025-11-11
“The passage provides routine financial statistics on publicly traded cannabis firms in Canada with n”
Directory of Private Cannabis Companies Listed in House Oversight Document
2025-11-11
“The passage merely lists cannabis businesses and their websites without any allegations, financial f”
Sources
1 source for known connections
Co-Document Mentions
“Named alongside other network members in 93 documents”
Known Connections (7)
Document Mentions (220)
Directory of Private Cannabis Companies Featured in House Oversight Report
The passage lists several private cannabis producers and their products without mentioning any high‑profile individuals, government agencies, financial transactions, or alleged misconduct. It offers n Level Blends – California cannabis concentrate producer. Lunchbox Alchemy – Oregon cannabis edibles and concentrates maker. LivWell Enlightened Health – Colorado/ Oregon dispensary operator and culti
Cannabis Industry Company Listings in 2017 Investment Report
The passage lists several small cannabis businesses and a research firm with no mention of high‑profile officials, financial misconduct, or controversial actions. It provides no actionable leads, date Identifies Auntie Dolores, a cannabis edibles producer in Oakland, CA. Lists BAS Research, a cannabis oil extraction and manufacturing firm in Berkeley, CA. Mentions Baker Technologies, a CRM platfor
Cannabis Investment Report – Comparison of U.S. Stock Market Listing Requirements (Dec 2017)
The passage only provides generic data on listing standards for Nasdaq, NYSE, and OTC markets. It contains no references to influential actors, financial flows, misconduct, or investigative leads. Most cannabis‑related public companies trade on the OTC due to looser requirements. Nasdaq and NYSE have higher minimum share prices and stricter governance standards. OTC tiers (OTCQX, OTCQB, OTCPink) v
Canadian Public Cannabis Companies Market Overview (Nov 2017)
The passage provides routine financial statistics on publicly traded cannabis firms in Canada with no indication of wrongdoing, influential actors, or novel controversy. It lacks actionable leads, spe As of Nov 30, 2017, 6 firms on TSX, 20 on TSXV, 41 on CSE. Combined enterprise value of Canadian cannabis firms was $210.6 billion. Stock performance boosted by Trudeau's recreational cannabis announ
Directory of Private Cannabis Companies Listed in House Oversight Document
The passage merely lists cannabis businesses and their websites without any allegations, financial flows, or connections to high‑profile officials. It offers no actionable investigative leads, novelty Names and locations of several private cannabis firms (Beboe, BioTrackTHC, Berkeley Patients Group, Brief description of each company's products or services.
Cannabis Industry Report Listing Companies and Platforms (Dec 2017)
The passage is a generic industry directory with no mention of influential political actors, financial flows, or misconduct. It provides only company names and URLs, offering no actionable investigati Lists KIVA Confections, LeafLink, Korova, and Leafly as cannabis-related businesses. Includes locations and website URLs for each company. Identifies the document as a Cannabis Investment Report date
Ackrell Capital Cannabis OTC Market Valuation Table (2017)
The document is a financial listing of small OTC cannabis companies with market metrics. It contains no references to influential political figures, government agencies, or alleged misconduct, offerin Provides EV multiples and stock price discounts for over 40 cannabis firms. Compiled by Ackrell Capital, a FINRA/SIPC member. Data dated November 30, 2017.
Directory of Top 100 Private Cannabis Companies (2018) with Company Descriptions
The passage is a simple listing of cannabis businesses and their services, lacking any mention of influential political figures, financial misconduct, or investigative leads. It provides no actionable Lists several cannabis companies and their product offerings. Includes website URLs and locations for each company. Mentions Ackrell Capital, LLC as a FINRA/SIPC member.
Ackrell Capital Cannabis Market Forecast Lacks Direct Political or Financial Misconduct Leads
The document is a commercial market analysis of legal cannabis, containing no specific allegations, transactions, or connections to high‑profile officials or agencies. It offers no actionable investig Provides global cannabis consumption estimates and market size projections. Mentions countries with medical cannabis laws and predicts future recreational legalization. Outlines methodology based on
Scientific overview of CBD pharmacology and clinical trials
The passage provides general medical information about CBD and mentions pharmaceutical companies, but contains no specific allegations, financial flows, or connections to powerful officials. It offers Describes the endocannabinoid system and CBD's mechanism of action. Lists FDA‑approved CBD drug (Epidiolex) and companies conducting trials. Notes safety profile and potential drug‑interaction risks
Synthetic Cannabis Overview Lacks Investigative Leads
The document is a generic informational summary about cannabinoids with no mention of individuals, transactions, or wrongdoing. It provides no actionable leads, novel allegations, or connections to po Describes types of cannabinoids and FDA approvals. Lists potential therapeutic uses of various phytocannabinoids. Cites Cowen and Company as source.
Ackrell Capital Cannabis Investment Report compares market size to alcohol, coffee, tobacco, and pharmaceuticals
The document is a commercial investment analysis with no mention of political figures, government agencies, or alleged misconduct. It offers no actionable leads for investigations and contains only pu Provides estimated penetration rates and consumer spending for cannabis versus other legal substance Claims U.S. legal cannabis market size aligns with other retail markets. Published by Ackrell Capi
List of Private Cannabis Companies from 2018 Report
The document is merely a catalog of cannabis industry firms without any allegations, transactions, dates, or connections to high‑profile individuals or agencies. It offers no actionable investigative Compilation of over 100 private cannabis companies from a 2018 report Includes brand names, labs, dispensaries, and investment entities No mention of government officials, financial flows, or miscond
Cannabis Investment Report – December 2017 Financial Metrics
The document is a financial summary of cannabis‑related public companies with valuation multiples and revenue figures. It contains no references to political figures, government agencies, foreign lead Provides LTM and forward revenue, EBITDA, and enterprise value for several cannabis firms. Lists stock tickers and market percentages for each company. Notes methodology for handling negative or extr
Ackrell Capital Cannabis Investment Report Shows Strong Stock Gains Post‑Trump Election
The document is a routine market analysis of publicly traded cannabis companies with no mention of specific individuals, transactions, or wrongdoing. It offers no actionable investigative leads and re U.S. cannabis‑related stocks rose sharply from late 2016 through 2017. The report notes that the election of Donald Trump and appointment of Jeff Sessions did not dampen p Data sourced from S&P Globa
Showing 15 of 220 documents. View all →
This dossier on Annabi was compiled from court records, flight logs, and public documents. 100% free, ad-free, and independent.